Translational Competitors
| TDAC Stock | USD 10.51 0.04 0.38% |
Translational Development vs Cantor Equity Correlation
Very weak diversification
The correlation between Translational Development Acqu and CEP is 0.52 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Translational Development Acqu and CEP in the same portfolio, assuming nothing else is changed.
Moving together with Translational Stock
Moving against Translational Stock
Return On Tangible Assets is expected to grow at the current pace this year. The current year's Return On Capital Employed is expected to grow to -0.0012. At present, Translational Development's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 785.2 K, whereas Non Currrent Assets Other are projected to grow to (18.5 T).Translational Development Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Translational Development and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Translational and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Translational Development does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Translational Stock performing well and Translational Development Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Translational Development's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MACI | 0.11 | 0.01 | (0.11) | (0.46) | 0.00 | 0.19 | 1.04 | |||
| CEPO | 0.19 | (0.02) | 0.00 | (0.69) | 0.00 | 0.47 | 1.81 | |||
| HCMA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| FACT | 0.28 | 0.00 | (0.06) | 0.09 | 0.37 | 0.77 | 2.10 | |||
| WLACU | 1.69 | 0.32 | 0.00 | 2.07 | 0.00 | 7.25 | 30.46 | |||
| NTWO | 0.08 | 0.00 | (0.14) | 0.16 | 0.00 | 0.29 | 0.86 | |||
| SZZL | 0.12 | 0.00 | (0.10) | 0.44 | 0.09 | 0.39 | 1.18 | |||
| CEP | 5.93 | (0.84) | 0.00 | (1.93) | 0.00 | 11.42 | 42.44 |
Cross Equities Net Income Analysis
Compare Translational Development and related stocks such as Melar Acquisition Corp, Cantor Equity Partners, and HCM Acquisition Corp Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CEPO | (6.29) | (6.29) | (6.29) | (6.29) | (6.29) | (6.29) | (6.29) | (6.29) | (6.29) | (6.29) | (6.29) | (6.29) | (6.29) | (3.47) | (84.4 K) | (76 K) | (72.2 K) |
| FACT | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 6 M | (269.6 M) | (56.5 M) | (50.8 M) | (53.3 M) |
| SZZL | (10.57) | (10.57) | (10.57) | (10.57) | (10.57) | (10.57) | (10.57) | (10.57) | (10.57) | (10.57) | (10.57) | (880.6 K) | (253.8 K) | (134) | (134) | (154) | (162) |
Translational Development and related stocks such as Melar Acquisition Corp, Cantor Equity Partners, and HCM Acquisition Corp Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Translational Development financial statement analysis. It represents the amount of money remaining after all of Translational Development Acquisition operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Translational Development Competitive Analysis
The better you understand Translational Development competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Translational Development's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Translational Development's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Translational Development Competition Performance Charts
Five steps to successful analysis of Translational Development Competition
Translational Development's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Translational Development in relation to its competition. Translational Development's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Translational Development in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Translational Development's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Translational Development, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Translational Development position
In addition to having Translational Development in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run USD Crypto Fund Thematic Idea Now
USD Crypto Fund
Fund from digital currency traded on multiple global exchanges in US dollors. The USD Crypto Fund theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Fund Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Translational Development Correlation with its peers. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Will Diversified Capital Markets sector continue expanding? Could Translational diversify its offerings? Factors like these will boost the valuation of Translational Development. If investors know Translational will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Translational Development data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Translational Development is measured differently than its book value, which is the value of Translational that is recorded on the company's balance sheet. Investors also form their own opinion of Translational Development's value that differs from its market value or its book value, called intrinsic value, which is Translational Development's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Translational Development's market value can be influenced by many factors that don't directly affect Translational Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Translational Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Translational Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Translational Development's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.